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Abstract
Hospitalization and revascularization treatment for patients with acute myocardial
infarction (AMI) is an economic burden that can be minimized by identifying patients most
likely to benefit. To this end, a non-invasive imaging technique to better characterize
myocardial salvage may be helpful. In this thesis work, a functional CT technique is
examined to assess at-risk, infarcted, and salvageable myocardial tissue. Data was acquired
on a cohort of seven pigs with induced AMI during the acute and sub-acute phases post
insult. The tracer kinetic model dependent CT images were validated against both T2-TIRM
images and quantitative T1-maps acquired using MRI, as well as constant infusion CT
images. Extravascular contrast distribution volume (ECDV) and myocardial perfusion (MP)
parameters were used to characterize the injured myocardium. Derived ECDV and MP
threshold for acute phase MI in seven pigs is 0.36 ml/g and 0.44 ml/min/g, respectively.
Average MP in normal, at-risk and infarcted myocardium were 0.92  0.27, 0.80  0.19, 0.30
 0.08 ml/min/g, respectively. Average ECDV in normal, at-risk, and infarcted myocardium
were 0.13  0.08, 0.21  0.07, 0.60  0.12 ml/g, respectively. Significance was demonstrated
in both MP and ECDV measurements between infarcted myocardium and myocardium atrisk, as well as between infarcted and normal myocardium (p< 0.01). Based on the area
estimated using ECDV and MP, at-risk, infarcted, and salvageable myocardial tissue can be
delineated.
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CHAPTER 1

1

INTRODUCTION

Acute myocardial infarction is the leading cause of death in Western countries. It
remains a significant problem with great economic burden dedicated to patient
management and treatment. Therefore, a guideline to triage patients for
revascularization treatment will be of tremendous value for those involved in this
process.

1.1 Acute Myocardial Infarction: A consequence of coronary
artery disease
Coronary artery disease (CAD) occurs when one or more of the three main arteries
supplying oxygen and nutrients to the heart muscle become damaged (1). Acute
myocardial infarction (AMI) or heart attack is a consequence of CAD. It develops when
regions of the heart become necrotic due to shortage of oxygen required for cellular
metabolism, with prolonged ischemia (restricted blood supply). The majority of AMI
events (9 out of 10) are caused by atherosclerosis, which is defined as the build-up of
plaques that narrow or occlude a portion of the blood vessel (2). However, AMI is most
often caused by an abrupt blockage of the vessel due to the rupturing of vulnerable
plaque. This restricts the delivery of nutrients and causes ischemic injury that impairs the
myocardium downstream of the occlusion site. Ischemic injury continues to advance until
the affected artery is treated and blood supply is restored. If revascularization treatment is
not pursued, perfusion to the myocardium will not be restored.
The severity of myocardial damage is dependent on the duration of unrelieved ischemia
(3). Permanently irreversible damage (infarction) follows when the occlusion remains
unresolved. Dense fibrous scar tissue takes the place of infarcted myocardium over time,
and cardiac function becomes impaired. Symptoms of AMI are highly variable among the
patient population. Common symptoms include chest and upper body discomfort, sweat,
nausea, shortness of breath, and light-headedness. Some studies correlate the occurrence
of AMI to time of day, with a greater incidence during the early morning hours as a
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response to increased heart rate, blood pressure, and cardiac output in comparison to the
later hours of the day (4). The symptoms listed above are common amongst many disease
types. Hence, diagnosis and treatment planning remain ambiguous with clinical
symptoms alone.
The aim of chapter one is to present the global burden of heart disease. It will define the
group of patients who are most likely in need of further functional tests for conclusive
diagnosis, and revascularization treatment guidance. Furthermore, the imaging techniques
that are currently available and practiced in clinic for the assessment of AMI will be
discussed; as well as the clinical implications of the novel functional CT technique
described in chapter two, with the potential to triage patients for revascularization
treatment.

1.1.1

Prevalence, mortality and economic burden of CAD

Diseases of the heart are the leading cause of death in the United States with 27.6 million
diagnosed Americans (5,6). Within this population, approximately 610, 000 lives are lost
to heart disease annually. In Canada, one in every twelve Canadian adults over the age of
21 is diagnosed with heart disease, and it is identified as the second leading cause of
death with approximately fifty thousand individuals (7,8); this number represents twenty
percent of the total number of deaths in 2013, as indicated by Statistics Canada. Heart
disease is not prominent in one sex over another – it affects men and women equally. It is
also agreed that the prevalence of the disease increases with age.
Heart disease makes up the majority of cardiovascular disease (CVD). Generally, CVD
refers to different conditions that involve the loss of perfusion to different organ tissues
that constitute the cardiovascular system. This includes CAD, heart failure, stroke, and
hypertension. The American Heart Association and the American College of
Cardiology’s (AHA/ACC) 2018 statistical update suggests at least 130 million American
adults are expected to be diagnosed with a form of CVD by the year 2035, by which time
point the economic burden of CVD is estimated to reach $1.1 trillion per year (6). The
majority of this cost is attributed to hospitalization and treatment of the diseased patients.
Within the CVD population, 43.8% of deaths are associated with CAD, making it the
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most common form of heart disease (9). In Canada, AMI caused by CAD is one of the
top five reasons for inpatient hospitalization (10). Between the years 2016 and 2017,
seventy thousand patients were hospitalized for an average of five days.
Currently, patients require comprehensive assessment upon arrival at the hospital. In
certain cases, these patients are left untreated because they yield inconclusive results.
This can potentially extend beyond the window of opportunity for revascularization
treatment for patients who require immediate attention. To reduce the time between
patient arrival at the hospital and transfer to the catherization lab, it is crucial to challenge
current clinical guidelines in place for AMI patients, such that the most practical methods
can be implemented to aid those in need of intervention, while limiting hospital expenses.

1.1.2

Management of acute coronary syndrome

Acute coronary syndrome (ACS) is an umbrella term that summarizes three conditions
that result in a reduction of blood supply to the myocardium due to an abrupt blockage.
Figure 1-1 provides an overview of the three ACS categories characterized based on
electrocardiographic (ECG) recordings and blood work: ST segment elevation
myocardial infarction (STEMI), non-ST segment elevation myocardial infarction
(NSTEMI), and unstable angina (UA). When ACS is suspected, the 2014 AHA/ACC
guidelines for management of patients with ACS suggest ECG tracings be acquired
within 10 minute of hospital admission and monitored sporadically at 15 to 30-minute
intervals to observe the dynamic changes in the presence of ischemic episodes (11).
Prolonged ST-segment elevation that deviates from previous baseline tracings is
indicative of abrupt epicardial coronary artery occlusion(s) resulting in myocardial injury.
Patients with STEMI are those with complete occlusions. These patients are unstable and
urgently require revascularization treatment (11-13).
On the other hand, ACS patients who show no elevation of the ST segment require
further testing before they can be classified into NSTEMI and UA. The ST-segment in
this group of patients is not as prominent or distinct because the occlusion is partial or
temporary. Blood tests are typically performed to determine the concentration of cardiac
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biomarkers, such as troponin. Cardiac troponin is expressed exclusively in the heart and
is effective in differentiating UA and NSTEMI. Levels of troponin T and troponin I are
sensitive and specific indicators of myocardial damage that transpires with AMI (14,15);
the greater the concentration of troponin T and I, the greater the volume of myocardial
necrosis. For patients suspected of NSTEMI or UA, both the ECG and troponin levels are
monitored at baseline (arrival) and throughout hospitalization, as changes in biomarker
concentration can provide an understanding of the degree of myocardial impairment.
Change of twenty percent or more from baseline troponin level are considered a
significant increase. Patients presenting this change are classified as NSTEMI.
The third subcategory of interest comprises the patients with UA. Patients with UA have
symptoms of severe, repeated chest pain that can potentially progress to myocardial
infarction when left untreated. As UA patients have not experienced a heart attack or
ischemia, troponin levels remain relatively stable over time—change less than 3 standard
deviation between successive measurements—yielding inconclusive results.

Figure 1-1 Categorization of STEMI, NSTEMI, and UA within ACS. Each subtype
can be identified by ECG readings and blood sampling for cardiac biomarkers.
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Because the combination of ECG tracings and troponin-level measurements yield
inconclusive results, an additional non-invasive functional test is required to facilitate
optimal patient management. This is especially important as statistics indicate two
percent of patients discharged after presenting with asymptomatic serial ECG, biomarker,
patient history, are later diagnosed with MI with greater risk of mortality (16,17). For
these patients suspected of future episodes of MI, a non-invasive imaging technique may
prove to be an advantageous diagnostic tool that can further characterize ischemically
injured tissue to triage patients for revascularization treatment.

1.1.3

Revascularization treatment

When diagnosed with AMI, patients undergo revascularization via percutaneous coronary
intervention (PCI, formerly known as coronary angioplasty). PCI is the primary nonsurgical choice of treatment for AMI patients. This treatment requires cardiac
catheterization, where a balloon catheter is advanced through the arm or groin, and
guided to the region of occlusion by fluoroscopy. For structure support and guidance
through the anatomical vessel, the balloon is placed within a metal stent. The balloon is
inflated once the catheter traverses the stenosis to allow revascularization by compressing
the plaque mass to the walls of the artery. When blood supply is restored in the
myocardium in a timely manner, revascularization treatment is deemed successful and
can prevent irreversible damage.
PCI is the preferred treatment for STEMI patients who present at the hospital within 2
hours post symptom onset (18). For best clinical outcome, PCI treatment should be
performed within 120 minutes of diagnosis (19,20). In general, as in stroke studies, time
delay or ischemic time is shown to be directly proportional to infarct size (21).
Consequently, the left ventricular function (a measure of global cardiac function) become
inversely proportional to time to revascularization in AMI (3,21,22).
Coronary artery bypass grafting surgery (CABG) is an invasive form of revascularization
treatment, which is the most common open-heart surgery for NSTEMI-AMI patients.
Briefly, a healthy artery or vein harvested from elsewhere in the body is grafted to bypass
the blocked coronary artery thereby providing a new pathway for blood to access the
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myocardium. Although PCI is a reference procedure for revascularization, previous
clinical trials indicate CABG as the main standard of care for patients with complex
disease when multiple vessels are occluded (23).

1.1.4

Progressive changes in myocardial perfusion post AMI

Coronary blood flow is directly proportional to the oxygen requirement or consumption
of the heart. When the heart is stressed (e.g. exercise), the heart demands greater
concentration of oxygen, compensated by more coronary blood flow. With partial
occlusion of the artery, minimal oxygen is delivered through the occluded artery to meet
the energy required by the heart to maintain function. In STEMI subjects with a complete
occlusion, perfusion to the downstream muscles of the heart is completely lost in the
coronary artery responsible for nutrient delivery. The muscle’s alternative source of
oxygen supply is dependent on the development of collateral vessels, which also has an
upper limit. Collateral vessels can compensate the loss of coronary blood flow, but its
ability to maintain high demands of oxygen is determined by the advancement of the
collateral vessels of the subject. During the progression of AMI and the formation of a
complete occlusion, myocardial perfusion is lost with time. In addition, with greater
regions affected by MI there are greater degrees of microvascular obstruction (MVO) or
damage. The delivery of blood through the microvasculature is absent in tissue with
MVO.

1.1.5

Pathophysiology of AMI and myocardial edema

As discussed in section 1.1, AMI is caused by the blockage of an artery that supplies
blood to the heart. MI is the death of cardiomyocytes after extended oxygen deprivation
or ischemia. Infarcted myocardium cannot be salvaged because the adverse effects of
ischemic injury are detrimental. In contrast, myocardium at risk (MAR) that surround the
infarcted myocardium is not yet necrotic and can be salvaged when reperfused promptly.
Myocardial edema occurs in regions of MAR in the event of ischemia; however, edema
further extends in injured myocardium with revascularization after acute MI event.
Edema is a physiological response of interest for this project as it targets the patient with
partial or temporary stenosis with experienced ischemia and reperfusion. Following
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occlusion, the loss of blood flow downstream results in limited delivery of oxygen to the
tissue. Oxygen is an important reactant that the body requires to undergo a metabolic
process for the production of adenosine triphosphate (ATP), a major energy source
powering all other cellular processes in the human body. This metabolic process is
referred to as cellular respiration, where the body uses stored sugar molecules of glucose
and the available intake of oxygen to produce energy rich ATP (13,24-26).
ATP plays an important role in regulating the influx of water between the interstitial and
cellular space. The ATP dependent sodium-potassium (Na+/K+) pump regulates the
concentration of sodium and potassium inside and outside of the cell. For every three
sodium ions extruding from the cell, two potassium ions enter the cell through the Na+/K+
pump. In the absence of oxygen, the concentration of ATP is reduced because the cell is
unable to undergo cellular respiration. As a result, the ATP-dependent Na+/K+ pump
becomes dysfunctional and leaky, allowing water to diffuse into the cell during the
transportation of sodium ions (Figure 1-2) (25,26).
In normal myocardium, eighty percent of the myocardium is composed of water. Of this
water, 78% are water molecules that are tightly bound to proteins and other

Figure 1-2 Normal myocyte in the absence of ischemic injury (left). Injured myocyte
resulting from ischemic injury (right). Dash lines represent the loss of cell membrane
integrity, making the surface of the cell membrane highly permeable
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macromolecules (e.g. ribonucleic acid) within the myocyte. In oxygen deficient
circumstances, the cell can alternatively depend on anaerobic respiration to produce a
weaker source of energy, nicotinamide adenine dinucleotide (NAD+). NAD+ plays an
important role in energy metabolism when oxygen is not readily available in the body
system during environmental stress. Unfortunately, anaerobic respiration can only be
effective for a short duration, when tissues are deprived of oxygen and a ‘plan b’ is
required to maintain homeostasis. With prolonged occlusion where the supply of oxygen
is insufficient relative to the tissue demand, anaerobic respiration can have detrimental
effects on a molecular level.
A byproduct of anaerobic respiration is lactate. The sudden demand for anaerobic
respiration increases the concentration of lactate in the cell, forcing the intracellular
environment to be acidic. With abrupt decrease in pH, the proteins and macromolecules
that bind to the water molecules undergo a conformational change, which releases the
water molecules allowing localization throughout the intracellular space.

Figure 1-3 Fluid accumulation in the interstitial space of myocardium has two
sources: blood vessel (capillary) and free water molecules of the cell via
extracellular osmotic pressure forcing fluid to exit into the interstitial space.
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Free water molecules in combination with the Na+/K+ pump malfunction are the main
cause of cellular edema – the abnormal accumulation of water in a tissue – in the
myocardium post AMI. It is important to note that edema in the myocardium takes place
not only in the intracellular space but also in the interstitial space of the tissue.
Fluid accumulation in the interstitial space has two sources (Figure 1-3). The main source
of water is the blood vessel. Edema is the aftermath of an inflammation response to
stress, a precursor of Na+/K+ pump dysfunction. Like the Na+/K+ pump of a myocyte,
Na+/K+ pumps are present around the cell membranes of endothelial cells that line the
interior surface of the blood vessels. With ischemia, capillary membranes become semipermeable due to the damage of endothelial cells. This means that following AMI, the
endothelial cells undergo apoptosis, no longer able to guard the blood vessel from
allowing the entrance and evacuation of unwanted materials. The capillary membrane
becomes leaky, allowing fluid exchange between the vascular and interstitial space.
In addition to the leakiness of the blood vessels, the second source of edema in the
interstitial space is the osmotic pressure gradient between the intracellular and
extracellular space, forcing fluid to diffuse out of the edematous myocytes into its
neighboring interstitial compartment (Figure 1-3).

Figure 1-4 The wave front phenomenon with initial ischemic and most affected area
being the subendocardial region followed by subepicardial zone when a patient is left
untreated. Myocardium at-risk (MAR) is the total area of tissue that is infarcted
(irreversible injury) and can be salvaged (reversible injury). Assessment of MAR and
infarcted myocardium will provide an estimate of how much tissue can be salvaged
with intervention.
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Previous animal studies have shown that myocardial infarction follows a ‘wave front
phenomenon’, where the subendocardial regions of the heart are most affected by
ischemia and are first to become infarcted (27). Followed by the subendocardial regions
is the subepicardial layer or the extended borders of the myocardium at risk (MAR)
(Figure 1-4). Common characteristics of infarcted myocardium are the presence of
myofibrillar contraction bands, damaged mitochondria (either swollen or ruptured),
microvascular obstruction, and haemorrhage (27-29). The duration of unrelieved
ischemia will influence the presence and continuance of ischemic/reperfusion injury.
Comprehensive assessment of the injured tissue prior to proceeding with treatment is
necessary to reason how much tissue is at risk and infarcted to estimate how much can be
salvaged.

1.2

Diagnostic imaging for early detection of AMI

As stated in section 1.1.2, a non-invasive imaging technique may prove useful in tissue
characterization for NSTEMI and UA patients with inconclusive results during the
primary examinations performed upon arrival at the emergency department. Diagnostic
imaging techniques take advantage of the cascade of physiological events that occur
during hypoperfusion and reperfusion, to evaluate myocardial tissue state. Three tissue
states of interest are infarcted and salvageable tissue, which together represent at-risk
myocardium. This section will briefly describe the most commonly used imaging
techniques for cardiac tissue evaluation as well as techniques to measure cardiac
function. The following imaging techniques are used to evaluate CAD in both acute and
chronic stages of MI. Not all of these techniques are routinely practiced for diagnosis of
AMI (the focus of this thesis work). Echocardiography, single photon emission computed
tomography (SPECT), magnetic resonance imaging (MRI), and x-ray computed
tomography (CT) are common modalities for cardiac imaging. The preference of one
imaging method over another is based on the specific information that the user wants to
acquire. Three types of assessments are of importance: anatomical, mechanical, and
functional. The purpose of an anatomical assessment in AMI is to examine the degree of
lumen narrowing. Mechanical assessment can provide wall-motion abnormality
information. The most direct assessment of tissue state (quantity of reversible tissue
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relative to necrotic tissue) is by acquiring functional data. In the following section, the
most prominent imaging modalities, and their role in assessing AMI will be discussed
briefly.

1.2.1

Echocardiography

Echocardiography is a noninvasive imaging tool that is available at the bedside to
visualize myocardial wall function during an ischemic process. Two-dimensional (2D)
images are produced by the use of ultrasound for anatomical assessment, as well as
myocardial function. Although echocardiography is not commonly used in diagnosing
patients with AMI, echocardiography is a staple in clinical cardiology. In patients
suspected of AMI, this imaging tool can locate abnormalities in wall motion (for
example, myocardial stunning) and myocardial thickness. Echocardiography can also be
used as a monitoring tool at the bedside to locate mechanical complications after MI
event, to determine if a patient needs further treatment.
To improve contrast between ventricle and myocardium, technologist can choose to
intravenously administer the patient with microsphere contrast agents. Echocardiographic
contrast agents approved and used in clinic are Optison and Definity which are perflutren
protein type A and perflutren lipid microspheres, respectively. Contrast echocardiography
is useful it that it can also provide perfusion information in real time. Previous studies
have proven the use of contrast echocardiography pre- and post- revascularization to
assess the area at risk, in addition to infarct size (30). Overall, echocardiography of the
heart is a practical approach to estimate global cardiac function of a patient; but a major
limitation of this imaging technique worth mentioning is its high variance in image
quality between operators.

1.2.2

Cardiac magnetic resonance imaging

MRI is used to investigate CAD in both acute and chronic MI. In diseases, such as stroke
and AMI, MRI has been used to characterize tissue state with sufficient spatial resolution
and excellent soft tissue contrast. In this section, two MRI techniques: gadolinium
enhanced T1-mapping and T2-weighted (T2-w) imaging used to image myocardial
viability will be discussed, with respect to its application for MI.
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1.2.2.1

Post gadolinium enhanced T1-mapping

Gadolinium enhanced T1 mapping has been used for tissue characterization and
assessment of myocardial viability (31,32). As the name suggests, it requires the
administration of exogenous extracellular contrast agents to improve sensitivity.
Gadolinium-DTPA (diethylenetriamine penta-acetic acid) is a Food and Drug
Administration (FDA) approved contrast agent used in MR imaging, and is used to
shorten the T1 spin-lattice relaxation time. Gd-DTPA accumulates in injured
myocardium as a result of increased permeability in the interstitial and cellular space
after AMI. Therefore, injured myocardium with retention of Gd-DTPA will appear
hypoenhanced in gadolinium enhanced T1-maps; and can be delineated as MAR.
A limitation of gadolinium-enhanced imaging is the introduction of exogenous contrast
agent to the body. Although it is a tracer amount of contrast, with the assumption that it
takes no part in any physiological processes, it becomes problematic in patients subjected
to renal failure. In patients with poor kidney function, gadolinium will retain in the body
and cannot be cleared. This is a potential risk factor to consider in patients with history of
kidney disease.

1.2.2.2

T2-weighted imaging

T2-weighted cardiac magnetic resonance imaging is sensitive to free water molecules in
tissue. In AMI, it is useful in direct assessment of tissue edema (a marker of myocardium
at risk of further infarction) (33). With this imaging technique, fluid filled regions of the
tissue appear hyperenhanced relative to remote normal myocardium. It is a useful tool in
delineating MAR in acute stages of MI, when myocardial edema is most prominent. MRI
scientists have demonstrated the reduction in fluid over time after investigation of
patients with MI at acute and chronic stages after ischemic insult (34).
T1-mapping to detect infarct and T2-w imaging to delineate MAR is shown to improve
diagnostic accuracy in identifying tissue with reversible injury (24). Although this
technique is practiced in the clinic, it is not practical in emergency settings since the MRI
scanner is not accessible in most hospitals around the clock, and requires highly trained
operators.

13

1.2.3

Single Photon Emission Computed Tomography

SPECT imaging is frequently used in clinic to assess myocardial perfusion for the
evaluation of CAD. It is a nuclear medicine tomographic imaging technique which uses
gamma rays and a gamma camera. A radioactive tracer – typically containing
Technitium-99m or Fluorine-18 – is injected into the patient and the scanner detects
gamma rays that are emitted by the tracer within the body. SPECT imaging is commonly
combined with stress testing in patients with angina symptoms to reveal hemodynamic
information prior to revascularization (37). This allows for comparison of myocardial
perfusion measurements in myocardium at stress and myocardium at rest. The significant
change in myocardial perfusion between stress and rest provide information on the degree
of myocardial damage. Limitations of SPECT imaging is its sensitivity and radiation dose
of approximately 4.5 mSv; which is higher than DCE-CT (3 mSv).

1.2.4

Coronary computed tomography

CT scanners have become one of the most available diagnostic and screening tools
available in the hospital around the clock over the past decade. Their use has become
more prominent with the ability to acquire axial and helical diagnostic images within
seconds, facilitating patient throughput. Recent advances in CT technology have enabled
the acquisition of high-resolution three-dimensional coronary angiograms in time periods
shorter than fifteen minutes, including preparation time.
Coronary computed tomography angiography (CCTA) uses x-ray beams and exogenous
contrast agents, such as iodine, at high tube current for anatomical assessment with great
accuracy. The greatest advantage of CCTA is its ability to detect the site of stenosis and
the degree of lumen narrowing at the site of interest. It is time efficient and noninvasive,
while remaining an effective diagnostic approach (35). However, although CCTA is
highly sensitive to the localization of the occlusion by imaging the distribution of contrast
agent in the blood vessel and identifying the hypoenhanced region (site of occlusion
where iodine cannot enter), it is not useful in evaluating the haemodynamic influence of
the stenosis on the downstream myocardium. In other words, CCTA is not a tissue
viability test and can only identify the presence of stenosis. Multicenter studies have
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praised its ability to detect occlusion sites but have criticized its high negative predictive
value with regards to assessing physiological ischemia (36,37).
To triage AMI patients for revascularization treatment, tissue viability (i.e. how much
tissue can potentially be salvaged) is of interest. To do so, functional physiological
parameters must be considered (38). For example, studies have emphasized perfusion
measurements that can be obtained in conjunction with CCTA for improved evaluation of
CAD severity, as 50% of stenosis located using CCTA alone is a poor predictor of
ischemic injury (39,40).

1.2.5

Dual energy computed tomography

Spectral imaging or dual energy CT is a type of CT protocol that utilizes two different
energy spectra (typically, 80 kVp and 140 kVp for clinical application). The main
advantage of dual energy CT is its ability to decompose different anatomical features (i.e.
differentiating bone, water, and blood vessels) (41). Material of unknown composition
can be represented as a ratio of previously determined elements. Typically, the reference
elemental composition of known value is water and iodine (exogenous extracellular CT
contrast agent); and an unknown material would be identified as the ratio of water and
iodine concentration.
A research topic of interest in MI to study the chronic stages post MI is the use of ‘iodine
mapping’ to detect scar tissue (42). Iodine mapping is a static image acquired at peak
enhancement of contrast in the tissue to quantify the amount of iodine concentration
within a single pixel of the acquired image. Like MRI, CT requires the intravenous
injection of exogenous iodine contrast agents, which is retained in the extracellular space
of injured tissue. With basic knowledge of water and iodine density, iodine mapping can
make use of material decomposition to quantify the ratio of iodine to water concentration
within a single pixel to detect injured tissue and perfusion defects (43).The accumulation
of contrast in the injured myocardium is the consequence of myocardium remodeling at
the chronic stages of MI due to the dense fibrotic tissue content in the extracellular space.
The myocardium region where scar and fibrosis are present would appear hyperenhanced
with greater accumulation of iodine.
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An additional advantage of dual energy CT is its ability to reduce artifacts such as beamhardening effects (38). Beam hardening occurs as a result of greater attenuation of low
energy x-ray beams than higher energy x-ray beams. The average x-ray after the beam
passes the material will be higher due to this, i.e. hardening of the beam. This artifact can
be corrected during image reconstruction by producing a virtual monochromatic image at
a single energy (38,44).

1.2.6

Dynamic contrast enhanced computed tomography

Dynamic contrast enhanced (DCE) – CT is a functional imaging technique where a
patient is injected with contrast and the enhancement of contrast in the organ of interest is
monitored over time. During a dynamic imaging session of the heart, prospective ECGgating is used to acquire a set of scan images at the same diastolic phase of the cardiac
cycle (Figure 1-5). It provides functional information on the hemodynamics of the
myocardium that cannot be acquired from a standard anatomical CT (45). Previously,
DCE-CT images of the heart were acquired with retrospective ECG-gating technique,
where the subjects were scanned during the whole cardiac cycle. Images were
reconstructed retrospectively at a single cardiac cycle. With the advancement of
prospective ECG-gating where a single scan is acquired at a specific phase of the cardiac
cycle, the effective dose of radiation to the patient has been reduced from 12 mSv to
3mSv.

Figure 1-5 Ventilation suspension two seconds prior to a cardiac cycle and the scan
performed at the diastolic phase of the cardiac cycle (at 75% R-R interval).
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DCE-CT can be achieved using either a single energy or a dual energy CT to obtain
quantitative functional data. Single energy DCE-CT requires advanced post image
processing methods to correct for beam hardening effect. As mentioned in section 1.2.4,
dual energy CT may have an advantage over single energy CT; for example, beam
hardening correction and material decomposition.

Figure 1-6 General time enhancement curve acquired during DCE-CT study of tissue
(Q(t)) and arterial input (Ca(t)) used to derive functional parameters. Rapid scanning in
the first phase is to ensure the wash-in of contrast agent is accurately measured. The
second and third phase of the scan is at wider intervals to monitor the retention and
slow wash out of contrast from the myocardium.
A contrast-enhanced image of an organ of interest is not enough to yield functional
information. Tracer kinetic modeling for dynamic CT has been developed and used
extensively in the evaluation of tissue hemodynamics. A tracer kinetic model must be
applied to the time enhancement curve (in Hounsfield unit, HU) of the tissue and artery to
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derive functional parameters such as perfusion (blood flow), blood volume, and mean
transit time (Figure 1-6). This will be further discussed in section 1.2.6

1.2.6.1

Johnson Wilson Lee Model

Our lab has pioneered the Johnson Wilson Lee (JWL) capillary-tissue kinetic model to
facilitate quantitative measurement of tissue perfusion from a single bolus injection of
contrast medium and dynamic imaging session (44, 46). It has been applied to measure
myocardial perfusion in pigs with reperfused acute myocardial infarction and in patients
with known or suspected coronary artery disease (44). The JWL model describes the
kinetic behaviour of contrast medium in a single capillary transit in a realistic manner:
Firstly, it assumes that the concentration of contrast in the vascular space (capillaries) is
spatially non-uniform and has a concentration gradient from the arterial inlet to the
venous outlet. This assumption accounts for the exchange of contrast medium between
the vascular and interstitial spaces through passive diffusion during its first-pass
circulation. Secondly, it assumes that the contrast concentration gradient in the radial
direction within the vascular space is negligible compared to that in the axial direction
(from arterial to venous ends), because the flow rate in the axial direction is much greater
than that in the radial direction within the vascular space. Thirdly, the interstitium is
assumed to be a compartment, in which the contrast residues in the interstitium is well
mixed and the contrast concentration in the interstitial space is homogenous. This
assumption holds true because the capillaries in tissue are oriented randomly, hence,
contrast can enter the interstitial space in all directions which justified the assumption of
uniform mixture of contrast in this compartment. Furthermore, the rate of contrast
movement in the interstitium is much slower compared to the flow rate in the vasculature.
The distribution of contrast medium within the myocardium is governed by two
processes: (1) the wash-in and wash-out of contrast in and out of the vascular space via
perfusion; (2) Passive diffusion of contrast between the vascular and the interstitial space
through the permeable capillary endothelium. The bi-directional exchange of contrast
between the vascular and interstitial spaces is governed by rate constants K1 and k2.
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Figure 1-7 Flow-modified one-compartment Johnson and Wilson model of tracer
kinetics. K1 and k2 are the influx and efflux rate constants, P = permeability
coefficient, S = total surface area, Vv = volume of contrast in the vascular space, F=
local blood flow, Vi = volume of contrast in the interstitial space, Ca(t) = concentration
of contrast in the input artery, Cv(t) = concentration of contrast in the output vein.
The dynamic CT images acquired after a bolus injection of contrast can measure the
tissue and arterial time-enhancement curve (TEC). Together with tissue blood flow, K1
and k2 can be estimated from the measured TECs using the JWL model. The tissue and
arterial TEC have the following relationship:
Q(t) = F  [Ca(t)  R(t)]
= Ca(t)  [F  R(t)]

Eq. 1-1

= Ca(t)  RF(t)
where Q(t) is the tissue TEC, F is the blood flow in tissue, Ca(t) is the arterial TEC,  is
the convolution operator, R(t) is the impulse residue function (IRF), and RF(t) is the flowmodified IRF. The IRF is the theoretical delta function that describes the tissue response
to instantaneous delivery of contrast medium at the arterial inlet of the tissue. The height
of IRF is unity. The flow-modified IRF has the following mathematical forms:
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0
RF (t) = { F
F∙E∙

0 ≤ t < T0
T0 ≤ 𝑡 < T0 + W
F∙E
- (t-W)
e Vi

Eq. 1-2

t > T0 + W

where To is the contrast arrival time, W is the minimum transit time and Vi is the volume
in the interstitial space. At time less than To, no contrast is delivered in the tissue and
hence RF(t) remains zero. When contrast is delivered at the arterial inlet at To, RF(t)
becomes F and remains as F for the time less than the minimum transit time, during
which the contrast remains in the tissue. At time greater than W, a fraction of contrast is
washed out at the venous end, and RF(t) is equal to the product of flow and extraction
fraction (E) and an exponential term that describes the gradual decrease of contrast
concentration in the tissue over time.

1.2.6.2

Extended Johnson Wilson Lee Model

CT contrast medium is an extracellular agent and metabolically inert, and does not
distribute in tissue cells under normal condition. In the setting of acute myocardial
infarction where the cell membrane integrity in injured myocardium is altered, CT
contrast may gain access into the cellular space which may lead to a prolonged
accumulation (47-51). To account for the kinetics behaviour of contrast in acutely injured
myocardium, the JWL kinetic model is extended to simultaneously measure myocardial
perfusion (MP) and extravascular contrast distribution volume (ECDV) (Figure 1-8). The
latter parameter has a unit of mL per gram of tissue.
k1 to k2 in equation 1-3 are the rate constants describing the diffusion of contrast from the
vascular space to the interstitial space, and vice versa; k3 and k4 are the rate constants that
describe the diffusion of contrast from the interstitial space to cellular space, and vice
versa.
The RF(t) has the following forms governed by the extended JWL model:
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F
F
RF (t) = { ∙ E
G ∙ e-α(t-w-T0 ) + H ∙ e-β(t-w-T0 )
G = K1

k3 + k4 - α
β-α

and

T0 ≤ t < T0 + W
t = T0 + W
t > T0 + W

H = K1

β - k3 - k4
β-α

(k2 +k3 + k4 ) − √(k2 +k3 + k4 )2 − 4k2 k4
𝛼=

Eq. 1-3

2
(k2 +k3 + k4 ) + √(k2 +k3 + k4 )2 − 4k2 k4

𝛽=

2

Figure 1-8 Flow-modified two-compartment extended Johnson Wilson Lee model of
tracer kinetics to account for the exchange of contrast in the addition cellular
compartment. The dash line outlining the cellular compartment represents the loss of
cell membrane integrity in acutely injured cardiomyocytes, increasing contrast
permeability. K1 = rate of influx from vascular compartment to interstitial
compartment, k2 = rate of efflux from interstitial to vascular compartment, k3= rate of
influx from interstitial to cellular compartment, k4= rate of efflux from cellular to
interstitial compartment. P = permeability coefficient, S = total surface area, F= local
blood flow, V = volume of contrast, Ca(t) = concentration of contrast in the input
artery, Cv(t) = concentration of contrast in the output vein.
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For time between To and To + W, the form of RF(t) described by the extended JWL model
is identical to that described by the JWL model. The difference occurs at the time greater
than To + W, where the gradual washout of contrast in the tissue is given by dual
exponential terms in the extended JWL model to account for the involvement in both the
interstitial and cellular compartments.
In summary, ECDV in normal tissue (ECDVnormal) is equal to the volume of contrast in
the interstitial compartment (Vi). ECDV in infarcted tissue (ECDVinfarct) is equal to the
sum of the Vi and the volume in the cellular compartment (Vc). Thus, ECDV in infarcted
tissue will be greater than in normal tissue:
ECDVnormal = Vi ;
ECDVinfarct = Vi + Vc ;
ECDVinfarct > ECDVnormal .
ECDVinfarct = Vi + Vc =

1.3

G H
+
α β

Eq. 1-4

Rationale and Clinical Translation

AMI caused by partial or complete occlusion of one or more coronary arteries becomes
an economic burden from the moment of admission to treatment and care, followed by
re-hospitalization when required. Lack of blood flow and oxygen delivery are detrimental
to the myocardium, causing edema in the injured myocardial tissue. Myocardial edema is
a hallmark of the ischemic (hypo-perfused) myocardium that is at risk of irreversible
injury (infarction), and can be assessed non-invasively with T2-w MRI. Imaging the atrisk myocardium would be useful to inform decision making related to interventional
revascularization treatment, particularly for patients who do not receive treatment
promptly after a temporary or partial occlusion due to lack of evidence of salvageable
myocardium Specifically, these patients include NSTEMI and UA patients described in
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section 1.1.2. However, MRI is typically not available in the emergency setting and is
rarely used to assess patients with AMI.
On the other hand, DCE CT is a fast imaging technique and has the potential of being
widely available at hospitals; with many scanners sited in emergency departments. Our
group has developed a functional CT method for measuring the distribution volume of
contrast agent in the extravascular space of the myocardium and hypothesized that
ECDV, assessed by CT, can be a surrogate marker of myocardial edema in MAR.

1.4

Purpose and Hypothesis

The purpose of my thesis is to validate ECDV estimated using the functional CT
technique and to determine quantitative thresholds of ECDV and MP that can be used in
delineating the extent of salvageable myocardium. The hypothesis of my work is that
salvageable myocardium can be identified in DCE-CT as tissue that demonstrates the
presence of edema with depressed blood flow, while infarcted myocardium exhibits
marginal to no blood flow within the edematous region.

1.5

Thesis Overview

The overall objective of this research project is to demonstrate the potential use of DCECT to delineate salvageable myocardium by simultaneous assessment of edema and
myocardial perfusion in a single dynamic imaging session.
In chapter 2, I validated the ECDV metric quantified using the extended JWL tracer
kinetic model against the model independent constant infusion CT imaging method. We
wanted to ensure that the ECDV estimated using a tracer kinetic model is a true surrogate
of myocardial edema in injured myocardium after ischemic injury. After confirming
ECDV as a marker of edema, I derived ECDV and MP thresholds on the same subjects
used for validation at acute phase post AMI to delineate area of MAR, infarcted
myocardium, and salvageable myocardium. Lastly, I compared the areas measured using
the functional CT metrics to the area measured using the standard constant infusion CT
technique to identify salvageable myocardium.
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Chapter 2 is in preparation for submission as a paper to the Journal of the American
College of Cardiology: Cardiovascular Imaging entitled “Functional CT Imaging to
Identify Salvageable Myocardium for Acute Myocardial Infarction Management”.
The last chapter (Chapter 3) summarizes the thesis results, discusses the limitations of the
functional CT technique, and describe possible future work that will improve ECDV
measurement. This thesis work will conclude by discussing the clinical translation of the
functional CT technique.
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CHAPTER 2

2

Functional CT Imaging to Identify Salvageable
Myocardium for Acute Myocardial Infarction
Management

2.1

Introduction

Treatment for acute myocardial infarction (AMI) aims to restore flow to stenosed arteries
by percutaneous coronary intervention (PCI). PCI is effective when the procedure is
performed within the first 120 minutes from symptom onset but is most successful within
the first 60 minutes (1). Beyond this time window, the amount of myocardial tissue that
experiences irreversible damage significantly increases (2-5). Thus, rapid recognition of
AMI is required to facilitate the prompt application of PCI and to maximize its success.
Clinical symptoms and the incorporation of 12-lead electrocardiogram (ECG) are the
primary basis for revascularization treatment decision-making (6). These initial
assessments are sufficient to diagnose patients with ST-elevation myocardial infarction.
However, for patients with non-ST elevation myocardial infarction and unstable angina,
diagnosis cannot solely be made from knowledge of clinical symptoms and ECGtracings. These patients with partial occlusions have varying degrees of AMI but are
often overlooked due to the lack of significance in their preliminary tests; missing the
critical window for treatment.
Many studies have explored the use of imaging to improve diagnosis and prognosis of
AMI. Coronary computed tomography (CT) angiography can be useful in detecting the
location and size of an occlusion (7-11). However, it yields no functional information on
the hemodynamics or viability of the myocardium affected by the stenosis. The amount
of salvageable myocardium estimated using functional imaging techniques is a useful
metric for triaging patients; the more salvageable tissue, the more successful a
revascularization treatment (12). Delayed contrast-enhanced imaging using CT and
magnetic resonance imaging have shown promise in assessing myocardial viability by
quantifying the retention of contrast agent at equilibrium following slow infusion (13-22).
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However, this model-independent technique is impractical because of the time required to
achieve equilibrium between the tissue and the arterial blood pool (typically an hour).
An indicator of myocardial viability is the presence of salvageable myocardium, or
myocardium that is edematous with reduced perfusion relative to normal myocardial
tissue (23-28). In contrast, non-salvageable, infarcted myocardium is edematous but has
marginal to no perfusion. Salvageable myocardium is likely to become infarcted if not
addressed quickly.
Recently, So et al. explored dynamic contrast enhanced (DCE) CT imaging to assess
myocardial viability by simultaneously quantifying myocardial perfusion (MP) and
edema (29). So et al. assumed that the extravascular contrast distribution volume (ECDV)
within the injured myocardium could be a surrogate marker of edema. This metric is
derived from the extended Johnson-Wilson-Lee (JWL) tracer kinetic model, but has not
yet been validated by comparison to a model-independent technique. The present study
aims to: (1) validate myocardial edema as measured by ECDV against the modelindependent constant infusion CT imaging method, (2) derive thresholds of MP and
ECDV that can be used to quantify the amount salvageable myocardium, and (3) compare
the use of thresholds against the standard constant infusion CT technique to identify
salvageable myocardium.

2.2
2.2.1

Methods
Study design

For this study, a porcine AMI model that exhibits injury ranging from edema to infarct
was used. Although this model does not fully mimic clinical AMI, the range of injury is
sufficient to evaluate different methods of myocardial tissue injury characterization.
During the acute stage (3 days after AMI induction), the animals were imaged using both
CT and MR. Pre-contrast and post-contrast infusion CT images were acquired to produce
delayed contrast images of the heart. This constant contrast infusion technique provided a
model-independent way of assessing myocardial viability as well as a standard for
validating model-dependent metrics. T2-weighted turbo inversion recovery magnitude
(TIRM) images were also acquired as a standard for validation. Dynamic contrast
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enhanced CT images were acquired to obtain the model-dependent MP and ECDV
metrics. T1 maps were acquired to derive the MP and ECDV thresholds. Imaging was
repeated during the sub-acute stage (two weeks post-AMI induction). This study protocol
was approved by the Western’s research ethics board.

2.2.2

Animal model

Seven female Landrace pigs (40-70 kg) were used in this study. AMI was induced using a
catheter-based approach, where a balloon catheter was advanced to the distal left anterior
descending artery (LAD) and inflated to obstruct the downstream perfusion for one hour;
perfusion was restored after one hour. Anesthesia was induced by propofol (15-20 cc,
Novapharm Ltd, Scarborough, Ontario, Canada) and maintained with 2.0% isoflurane
(Baxter Corporation, Mississauga, Ontario, Canada). When required, Fentanyl (Sandoz
Canada Inc., Boucherville, Quebec, Canada) was administered at a dose of 1-2 mL for
pain relief.
In preparation for imaging, the pig was anesthetized with 1ml/20kg Telazol (reconstituted
with 5ml xylazine) IM. At 1.5 hours after initial administration of anesthetics, half the
original dose was delivered to maintain heart rate. The ventilator was set at
approximately 10 ml/kg (at a range of 7-15 ml/kg) to maintain low normal CO2 range,
and respiratory rate at approximately 20 bpm. Heart rate, body temperature, and partial
pressure of carbon dioxide were monitored and maintained throughout the course of the
scan. Ventilation was suspended approximately 2 seconds prior to the image acquisition,
as needed, to mimic breatholding.

2.2.3
2.2.3.1

Data Acquisition
Computed tomography imaging

To assess injured tissue when edema is present at the acute and sub-acute stages, subjects
were imaged on day 3 and day 12±3 post-AMI using CT. DCE-CT heart images were
acquired with a 64-row CT750 HD scanner (GE Healthcare, Waukesha, Wisconsin)
following a single bolus injection of iodine contrast agent (0.7 mL·kg-1 at 3 mL·s-1, 76%
iopadimol, Isovue multipack-370). Scans were prospectively ECG gated and acquired in
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the axial orientation, with a gantry speed of 0.35 s/rotation. A 3-phase protocol was used
for image acquisition: 1st phase, 22 scans every 1-2 heart beats; 2nd phase, 6 scans
acquired at approximately 14 s intervals; and 3rd phase, 4 scans acquired every 30 s. A
dual energy technique (140/80 kVp; 0.2 ms and 630 mA) was used using a rapid
switching x-ray tube.
Next, reference CT images were acquired for the constant contrast infusion protocol. Five
reference images were acquired prior to the infusion of the same dose of contrast agent
(0.7 mL·kg-1, 76% iopadimol, Isovue multipack-370), which was infused intravenously
over one hour. Another five images were acquired post contrast infusion when the
concentration of contrast in the tissue and the arterial blood pool reached equilibrium.
Equilibrium was confirmed by the state of no change in enhancement between the two
compartments over time. For each acquisition, 16 2.5-mm thick slices were
reconstructed.

2.2.3.2
2.2.3.2.1

Magnetic resonance imaging
T2-weighted imaging for edema

T2-w images of the heart were acquired on the same day as the CT study using a 3-Tesla
Siemens Magnetom Biograph mMR scanner (Siemens Healthcare, Erlangen, Germany).
Similar to the CT study, each scan was acquired during the diastolic phase of the cardiac
cycle following prospective ECG-gating. Ventilation was suspended for every slice
location at approximately two seconds prior to scanning to mimic breatholding. The turbo
inversion recovery magnitude sequence (TIRM), was used with the following scan
parameters: 5 slices in the axial orientation; TE: 47ms; TR:1363ms; TI: 180ms; flip
angle: 180; ETL: 12; matrix size: 256 x 256; slice thickness: 8mm.

2.2.3.2.2

Gd enhanced T1-mapping for salvageable myocardium

In addition, a gadopentetate dimeglumine contrast (Magnevist 0.1ml/kg) enhanced T1
map was obtained with a modified Look-Locker sequence. Contrast agent was
administered approximately 12 minutes prior to scanning and the scans were
prospectively ECG-gated. The sequence parameters were: 202 ms acquisition window;
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300ms trigger delay; three inversions at intervals of 80 ms; TR: 237.03ms; TE: 1.07ms;
flip angle: 35°; ETL: 1; matrix size: 192 x 192. The same 5 8-mm thick axial slices were
imaged with both sequences. Ventilation was suspended for every slice location at
approximately two seconds prior to the image acquisition to mimic breatholding.

2.2.4
2.2.4.1

Data Analysis
Dynamic contrast enhanced CT

The CT projection data were reconstructed as 70 keV virtual monochromatic images (2.5
mm thick) to reduce beam-hardening artifact. To reduce the effect of cardiac and
respiratory motion, partial scan reconstruction (180 degrees plus the fan angle) was
utilized. (A comparison of 360-degree reconstruction and partial reconstruction is
provided in Appendix A). Reconstructed images were averaged to yield seven, 5-mm
thick slices covering each subject’s heart. To remove the effects of residual cardiac and
respiratory motion between scans, 3D images were registered using a 3D non-rigid
registration algorithm (GE proprietary software) used on a GE advantage workstation
(version 5.0.9).

2.2.4.1.1

ECDV and MP functional maps

For each slice, ECDV and MP functional maps were generated from a set of 70 keV
virtual monochromatic DCE images using the extended JWL model of tracer kinetics,
which was incorporated into the CT perfusion software (GE Healthcare). To extract an
arterial input function Ca(t), a region of interest was manually drawn on the descending
aorta of the axial images. Myocardial regions of interest were also drawn as described in
section 2.2.4.3. The mathematical descriptions used to calculate ECDV and MP were
published previously by So et al (29). Briefly, the upslope of the tissue curve in relation
to the arterial curve of the descending aorta is used to estimate the absolute MP in
ml/min/g of tissue; the area under the third phase (wash-out of contrast) of the curves are
used to estimate the absolute ECDV in ml/g of tissue. Figure 2-1 shows a representative
DCE-CT image, along with time-enhancement curves and resulting ECDV and MP
functional maps.
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Figure 2-1 ECDV map and MP map of the left ventricular myocardium of a subacute phase infarcted pig post ischemic insults corresponding to the dynamic CT
image. A time enhancement curve (left) of the different myocardium region outlined
on the ECDV and MP map. The time enhancement curve of the injured tissue
(orange) shows higher elevation than the remote during the delayed phase of the scan
(50-250s), due to the retention of contrast agent.

2.2.4.2

Constant infusion CT

The constant infusion CT images were acquired and used as the reference standard
because it is a model-independent approach. The measured partition coefficient value is
not derived from a mathematical model but are calculated at equilibrium between the
tissue and the arterial blood pool. To improve the signal-to-noise ratio (SNR), adjacent
slices of the constant infusion CT acquisition were averaged into 5 mm images. Next,
images acquired pre and post contrast infusion were registered to each other using the
proprietary 3D non-linear registration method provided by GE, and the five pre- and five
post-infusion images were averaged to further increase the signal-to-noise ratio. A
difference image for each slice location was generated by subtracting the average precontrast image from the average post-contrast image, as shown in Figure 2-2; these
difference images were then used to calculate the partition coefficient (PC) of the tissue
at equilibrium. The change in signal intensity (SI) between the pre and post contrast
images, SIpre and SIpost respectively, provides information on the accumulation of iodine
contrast in different regions of the myocardium. Hence, PC is a surrogate marker of
iodine distribution volume. The partition coefficient is calculated as the volume
distribution of contrast in the total tissue region of interest (SItissue) normalized to the
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arterial blood pool (SIarterial blood); i.e. PC = SItissue / SIarterial blood at equilibrium. An
increase in PC in infarcted myocardium corresponds to an increased contrast distribution
volume as a result of edema and the additional space in which contrast can accumulate.

Figure 2-2 Difference image (right) generated by subtracting the pre-infusion image
(center) from the post-infusion image (left).

2.2.4.3

Assignment of coronary territory

In the pig, the axial scan orientation results in myocardial images parallel to the
horizontal long axis of the left ventricle (LV). Non-linearly registered DCE-CT images
were averaged across time to produce a static image that was used to outline the inner and
outer boundaries of the myocardium. These boundaries were used to define the
myocardium on the functional maps as well as the CI difference image. The LV was
divided into six segments based on the American Heart Association (AHA) horizontal
long axis nomenclature (Figure 2-3) (30). The apical septal and apical lateral walls,
shown in Figure 2-3 in purple and blue, respectively, are the regions supplied by the
occluded LAD. Thus, these regions contain the injured tissue. The injured tissue, or the
myocardium at-risk (MAR), is composed of both salvageable and infarcted myocardium.
The mid-lateral wall, shown in yellow in Figure 2-3, is supplied by the patent LCx, and
thus contains normal, uninjured tissue. The apical septal and the mid-lateral walls were
used as regions of interest for validation of the functional CT technique at the acute and
sub-acute phases after insult. The whole apical wall (septal + lateral walls) was used as a
region of interest (ROI) to define the MP and ECDV thresholds.
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Figure 2-3 Six segment horizontal long axis of the heart as defined by the AHA
(30). These segments are supplied by the left anterior descending (LAD), right
coronary (RCA), and the left circumflex (LCx) arteries.

2.2.4.4

Determination of MP and ECDV thresholds that define the
myocardium at-risk area

The MAR area was identified on T1 maps by selecting all pixels within the apical wall
ROI with T1-values three standard deviations away from the average T1-value in the
mid-lateral wall ROI. To find the corresponding MAR area within the CI difference
images used to validate model-dependent metrics, a threshold of 30 HU was used, as this
threshold consistently produced an MAR area that matched that measured with the T1map. All pixels above 30 HU were considered to be MAR in pigs without microvascular
obstruction (non-MVO, n=2).
In pigs with MVO (n=5), the threshold does not identify infarcted tissues, which are
hypoenhanced due to lack of contrast delivery. However, these hypoenhanced regions
were always surrounded by a hyperenhanced rim that is >30 HU. In these cases, the area
of hyperenhanced rim was considered to be the area of salvageable myocardium, while
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the hypoenhanced area was considered as the area of infarct. The sum of the areas was
the MAR area.
To determine the ECDV functional map threshold that yielded an MAR area that agreed
best with the MAR area determined from the CI images, the apical wall ROI in each slice
was “flooded” at thresholds ranging from 0.30 ml/g to 0.50 ml/g. For each threshold, the
combined area of all pixels above the threshold was calculated and compared to the MAR
area determined from the CI difference images.
A similar analysis was performed on the MP functional maps. The apical wall ROI in
each slice was flooded at thresholds ranging between 0.36 ml/min/g and 0.5 0ml/min/g.
This range of perfusion thresholds was selected based on previous studies showing that
MP <0.50 ml/min/g delineates infarcted myocardium (45,48). For each threshold, the
combined area of all pixels above the threshold was calculated and compared to the
infarcted area determined from the CI difference images. Since the infarcted area can
only be determined in cases with MVO, this comparison was restricted to MVO subjects
only. These analyses were performed using the acute phase (3 days post-AMI) images
only.

2.2.4.5

Statistical analysis

All statistical analyses were performed using GraphPad Prism 7 software. Using two
tailed t-tests, ECDV, PC, and T2-TIRM signal intensity (SI) values in the apical septal
wall territory were compared to the ECDV, PC, and T2-TIRM SI values in the midlateral wall territory, respectively. Significance was determined by p <0.05. Comparisons
were made with images acquired at the acute and sub-acute phases. Values were reported
as means of each region and standard errors between subjects.
To identify the ECDV and MP thresholds that yielded MAR and infarct areas that best
agreed with the CI-defined areas, Bland-Altman analysis was performed for each
threshold. The mean bias ± standard error was plotted as a function of threshold and
linear regression was performed. The ECDV and MP thresholds that yielded zero bias
according to the regression were selected as the thresholds that best separate injured from
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uninjured tissue. Areas with ECDV greater than the threshold were considered
myocardium at risk while areas with MP lower than the threshold were considered
infarcted myocardium. The mean ECDV and MP values in MAR, infarcted myocardium,
and normal myocardium were compared using two-tailed t-tests.
The areas of the thresholded ECDV and MP pixels within the apical wall were compared
to the MAR areas determined from the CI images. A comparison between the total area
of all thresholded pixels within the apical wall made (ECDV + MP) and the CI-defined
MAR area was also performed. These comparisons were made using two-tailed t-tests.
Both MVO and non-MVO cases were analyzed.

2.3

Results

2.3.1.1

Validation of ECDV versus constant infusion

The detection of the edematous region using the CT-derived ECDV functional map was
comparable to that achieved using the CI difference image and the T2 TIRM image
(Figure 2-4). ECDV in the apical septal wall during the acute (day 3) and sub-acute (day
12±3) phases post-insult was 0.39±0.04 ml/g and 0.46±0.08ml/g, respectively. As shown
in Figure 2-5, the ECDV in the mid-lateral wall was significantly lower than in the apical
septal wall at both the acute (0.14±0.01ml/g) and sub-acute (0.24±0.08 ml/g) phases
(p<0.05). Similarly, PC in the mid-lateral wall was significantly lower than that in the

Figure 2-4 (A) ECDV MAR depicted in the apical septal wall corresponds to the
enhanced region of on the CI difference image (B) and T2 TIRM image (C). Injured
myocardium is shown by the enhanced region (red arrow). The normal, uninjured
mid-lateral wall (green arrow) is not enhanced.
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apical septal wall for both phases (acute: 0.77± 0.05 vs. 0.37±0.04 and sub-acute:
0.80±0.04 vs. 0.37±0.01, p<0.05).

Figure 2-5 (top) ECDV (ml/g) in infarcted and normal myocardium at acute and subacute stages post insult. (center) PC in infarcted and normal myocardium at acute and
sub-acute stages post insult. (bottom) T2 TIRM signal intensity (a.u) in infarcted and
normal myocardium at acute and sub-acute stages post insult. Error bars represent
standard error amongst the subjects (* denotes p < 0.05). Injured myocardium is
represented by the apical-septal wall and the uninjured normal myocardium is
represented by the mid-lateral wall.

Change in ECDV and PC between normal and MAR within each subject is shown in
Figure 2-6. The same result was also observed in the T2-TIRM images. The signal
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intensities in the mid-lateral wall were significantly lower than the signal intensities in
the apical septal wall for both the acute and sub-acute phases. The corresponding signal
intensities in the at-risk and normal myocardium on acute and sub-acute phase T2 TIRM
images were 77.8±21.0 vs. 41.9±14.4 and 65.6±9.20 vs. 34.0±9.68 (p<0.05),
respectively.

Figure 2-6 (top) Difference of partition coefficient between MAR and remote
normal tissue is shown for each of the seven pigs at the acute and sub-acute phases.
(bottom) The same trends are seen for ECDV. (* denotes p < 0.05).

2.3.1.2

ECDV and MP thresholds

The mean bias between the thresholded ECDV area and the CI-derived MAR area are
plotted with respect to ECDV threshold value in Figure 2-7, along with the mean bias
between the thresholded MP area and the CI-derived infarct area, which are plotted with
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respect to MP threshold. Linear fitting determined that an ECDV threshold of 0.36 ml/g
and an MP threshold of 0.44 ml/min/g resulted in a mean bias of zero. The corresponding
R-squared values for the linear fits were 0.99 for both MP and ECDV.

Figure 2-7 (top) Mean bias of percent area difference between CI and ECDV plotted
on the y-axis. ECDV range plotted on the x-axis ECDV threshold of mean bias zero to
delineate MAR is 0.36 ml/g for acute phase MVO and non-MVO cases. (bottom)
Mean bias of percent area difference between CI and MP plotted on the y-axis. MP
range plotted on the x-axis. MP threshold of mean bias zero to delineate infarct is
0.44 ml/min/g for acute phase MVO cases. Error bars represent the standard error.
The derived MP and ECDV thresholds were used to determine the mean ECDV and MP
values in MAR, infarcted myocardium, and normal myocardium (Figure 2-8). As
expected, mean ECDV in normal myocardium < MAR < infarcted myocardium; mean
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MP in normal myocardium > MAR > infarcted myocardium. The mean MP  standard
error of infarcted myocardium, MAR, and normal myocardium were 0.30±0.07 ml/min/g,
0.81±0.19 ml/min/g, 0.93±0.27 ml/min/g, respectively. The mean ECDV  standard error
of infarcted myocardium, MAR, and normal myocardium were 0.61±0.12 ml/g,
0.22±0.07 ml/g, 0.13±0.07 ml/g, respectively. ECDV and MP can distinguish normal and

Figure 2-8 Mean MP (ml/min/g) and mean ECDV (ml/g) within different tissue
states: infarct, at-risk, and normal, determined by MP and ECDV thresholds of
0.44 ml/min/g and 0.36 ml/g, respectively. Error bars represent standard error of fortytwo slices from 7 pigs. (* denotes p < 0.05).
infarcted myocardium (p <0.05). ECDV and MP values were also able to distinguish
infarcted myocardium from MAR (p<0.05); however, no statistical difference was seen in
ECDV and MP measurements between MAR and normal myocardium.

2.3.1.3

Combining ECDV and MP to assess MAR

The apical wall ROI of an ECDV functional map flooded at 0.36 ml/g can identify MAR,
but cannot identify infarcted myocardium in subjects with MVO (n=5), as shown in
Figure 2-9, left. However, the apical wall ROI of a MP functional map can identify
infarcted myocardium at 0.44 ml/min/g. Figure 2-10 (bottom) shows the infarcted
myocardium determined by the MP threshold match the unidentifiable area on the ECDV
map at its derived threshold, when the maps are overlaid in subjects with MVO. In a
subject with no MVO (n=2), the apical wall ROI of a ECDV functional map flooded at
0.36ml/g can identify MAR, as illustrated in Figure 2-9, right. The apical wall ROI of a
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MP functional map flooded at 0.44ml/min/g can identify infarcted myocardium. The
infarcted myocardium is identified as a small area within a large area of MAR (Figure 210, top)

Figure 2-9 (left) contrast enhanced T1 map, CI difference image, MP, and ECDV
maps of a single subject (center slice) with MVO and with minimal MVO (right) The
colored regions correspond to the pixels flooded at specific thresholds. The ECDV
scale is 0 to 1.2ml/g and MP scale from 0 to 5.0ml/min/g). The white arrows point to
regions of MVO.

Figure 2-10 (top) subject with minimal MVO (bottom) subject with massive MVO.
Yellow = infarcted myocardium estimated at MP <0.44ml/min/g. Pink = MAR in nonMVO cases and salvageable myocardium in MVO cases determined as ECDV
>0.36ml/g. ECDV scale 0 to 1.2 ml/g and MP scale from 0 to 5.0 ml/min/g.
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The areas of the thresholded ECDV and MP pixels within the apical wall was compared
to the MAR area determined from the CI images, grouped into MVO and non-MVO
cases. A comparison was also performed between the total area of all thresholded pixels
within the apical wall (ECDV + MP) and the CI-defined MAR area in the group
subjected to MVO. For the group with no MVO, a comparison was completed between
the subtracted area of MP thresholded pixels from the area of ECDV thresholded pixels
within the apical wall ROI (ECDV - MP) and the CI-defined MAR area. Figure 2-11
(left) demonstrates a significant difference between the area of MAR measured through
CI difference imaging and MP (p<0.0001) or ECDV (p<0.001) alone. No statistical
significance was seen between MAR area calculated as the total area of MP and ECDV
(ECDV + MP), and the MAR area acquired through CI difference image (p>0.05). Figure
2-11 (right) exhibited significant difference between the area of MAR measured through
CI difference imaging and MP (p<0.005). In addition, statistical significance was seen
between MAR area calculated by subtracting MP thresholded pixels from an area of
ECDV threshold pixels (ECDV-MP), and the MAR area acquired through CI difference
image (p<0.005). No significant difference was seen MAR area estimated using ECDV
alone and CI difference image (p>0.05).

Figure 2-11 (left) MVO cases (n=5), comparing the area of infarct (MP), salvageable
myocardium (ECDV), myocardium at risk (ECDV+MP) to the myocardium at risk
area measured using CI. (right) non-MVO cases (n=2), comparing the area of infarct
(MP), myocardium at risk (ECDV), salvageable myocardium (ECDV+MP) to the
myocardium at risk area measured using CI. Error bars represent the standard error
amongst each slice between subjects. ** p < 0.005, *** p < 0.001, **** p < 0.0001.
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2.4

Discussion

In this study, the ECDV metric derived from the extended JWL tracer kinetic model was
used as a surrogate marker of edema in AMI. Our results demonstrated that the absolute
measurements of ECDV were higher in the apical-septal wall relative to the mid-lateral
wall. These findings were comparable to the patterns of edema measured using the
model-independent constant infusion CT method and T2 TIRM MR images; and were
indicative of edema in the extravascular space allowing greater retention of contrast
(24,26,27,31). Following the validation of myocardial edema as measured by ECDV
against the model-independent constant infusion CT imaging method, thresholds of MP
and ECDV were derived to be used to quantify the amount salvageable myocardium. This
study demonstrated the potential use for functional CT in quantifying the area of
salvageable myocardium, yielding comparable area of salvageable myocardium estimated
using the model independent constant infusion CT technique.
MP and ECDV thresholds determined based on our analysis on subjects of MVO and
non-MVO, imaged at the acute phase after infarct were 0.44 ml/min/g and 0.36 ml/g,
respectively. MP less than 0.44 ml/min/g delineated the infarcted myocardium that is
irreversibly damaged despite revascularization of the occluded artery. On the other hand,
ECDV values greater than 0.36 ml/g were indicative of MAR or salvageable tissue.
Although a strict threshold is determined, MP threshold of 0.44  0.02 ml/min/g (or 3%
deviance from mean bias of zero) and ECDV threshold of 0.36  0.03 ml/g (or 5%
deviance from mean bias of zero) is an acceptable range to identify areas of MAR and
infarcted myocardium.
In injured myocardium with high degree of MVO, the area of infarcted myocardium
plays a significant role and is prominent within the MAR. The salvageable myocardium
estimated in MVO cases will be minimal compared to non-MVO cases as the size of
infarcted myocardium in non-MVO cases with be minimal.
Previous studies have shown elevation in edema in injured myocardium using T2-w MR
imaging, which this study has confirmed in the acute and sub-acute phase after AMI
(23,31-34). In addition, model independent delayed enhancement CT and MR imaging
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were explored in other studies to assess MAR, with the assumption that retention of
contrast at equilibrium is a measure of excess space and fluid in the injured myocardium
17,18,20,22,34). The present study has tested the ECDV technique against a model
independent constant infusion CT imaging technique, which also assumes the retention of
contrast in injured myocardium to assess MAR.
Prolonged coronary artery occlusion in the absence of revascularization treatment leads
to damage at the microvascular level caused by inflammation, as a result of reperfusion
(35-37). The presence of MVO has been observed clinically and during animal-model
studies. The degree of MVO yields prognostic value; hence, MVO is of interest in the
imaging community during the investigation of salvageable myocardium. Contrast
enhanced T1 and T2-w MR imaging has been used concomitantly to assess salvageable
myocardium, and many of these studies were promising (12,33,34). Similar to our results,
late gadolinium enhanced MR images and gadolinium enhanced T1 maps displayed
patterns of hyperenhanced myocardium regions within a hypoenhanced myocardium rim.
The opposite pattern is seen in MR from CT because gadolinium shortens the T1
relaxation time, making the myocardium with contrast accumulation appear
hypoenhanced. This pattern detected with contrast enhanced MR is an imaging technique
used in the clinic to asses MVO (35). Comparable assessment of MVO injury can be
accomplished using MP and ECDV metrics estimated using the functional CT technique.
Consequently, the functional CT technique can be used to delineate salvageable
myocardium similar to MR imaging.
A limitation of this study was the variation in slice thickness between the MR and CT
images. The T2 TIRM and contrast enhanced T1-map used for this study were 8 mm in
slice thickness. In contrast, the CT images were reconstructed at 5 mm slice thicknesses.
Although the center slices were selected for the validation across modality, slight
differences in location of the heart can be detected. To address this study limitation,
images acquired using the four imaging techniques (T1 mapping, T2 TIRM, CI CT, DCE
CT) should be co-registered with each other to ensure the alignment of the images.
Another limitation of this study that must be addressed in the future is the lack of non-
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MVO subjects (n=2). To confirm our findings, a greater sample population of non-MVO
cases is needed.
Another major limitation that should be addressed in future studies is the prognostic
value of using ECDV and MP to triage patients for revascularization. Salvageable
myocardium delineated through ECDV and MP thresholds were not compared to the
ejection fraction measurements prior to revascularization. Whether or not ECDV and MP
provide comparable diagnostic and prognostic value as ejection fraction measurements
should be further investigated.

2.5

Conclusion

Partition coefficient, at equilibrium, has been validated (using MRI) as a means to assess
myocardial viability using CT. Unfortunately, in both MRI and CT, equilibrium between
tissue and the arterial blood pool can only be reached following prolonged constant
infusion of contrast agent, rendering such studies impractical for clinical use. The
functional CT technique proposed by So et al.(29), which introduced the extended JWL
tracer kinetic model to measure ECDV and MP simultaneously during a single imaging
session, data are acquired over only 4 minutes. The present study validated ECDV and
MP measured in an animal model of AMI and identified that a threshold of 0.36 ml/g and
0.44ml/min/g can delineate area of MAR and infarct myocardium; which can then be
used to estimate salvageable myocardium. The estimation of salvageable myocardium
will be useful in triaging patients for revascularization treatment for particularly
NSTEMI, UA, and late-arriving patients.
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CHAPTER 3

3

Conclusions and Future Work

The purpose of this chapter is to summarize the achievements of my thesis, provide
general conclusions, address the limitations of the research and provide suggestions for
the future work that can ultimately lead to the clinical use of DCE-CT in estimating
salvageable myocardial tissue.

3.1

Summary of Thesis Work

AMI is a leading cause of morbidity and mortality in America. A functional imaging
technique is needed to assess salvageable myocardium for proper patient management for
revascularization treatment. This will be useful to ensure that the patients who would
most likely benefit from treatment after MI are guaranteed revascularization treatment
within the window of opportunity. My thesis investigated the use of functional CT data
generated from a series of DCE images to which a tracer kinetic model that best
represented the pathophysiology of AMI was applied to delineate area of salvageable
myocardium.
Prior to my contributions to this area of research, Dr. Aaron So and Dr. Ting-Yim Lee
pioneered the extended JWL model of tracer kinetics to model the exchange of contrast
between different compartments of an injured myocardium (1-4). They defined this
distribution of contrast using ECDV and MP, and these parameters were validated against
the native T1-map and T2-w MR as reference in a previous paper (2). I began my
contribution to this thesis work by confirming Dr. So’s previous validation study with
T2-TIRM MR imaging and in addition, compared the ECDV measurements to a modelindependent constant infusion CT-based measurement. ECDV estimated from the
functional CT technique demonstrated an elevation in edema in injured myocardium
relative to normal myocardium. These findings validated that ECDV is a surrogate
measure of myocardial edema.
After validating ECDV as a surrogate measure of edema, against the previously
established standard of constant infusion, I investigated the potential clinical utility of the
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functional CT technique. Prior literature has demonstrated the usefulness of myocardial
perfusion imaging in detecting injured myocardium following ischemic injury (2-11). MP
together with the recent advent of ECDV can be used to characterize different
components of ischemically injured myocardium, which can be used to assess
salvageable myocardium. Therefore, I evaluated the hypothesis that the combination of
simultaneously acquired MP and ECDV functional maps would enable the detection of
infarcted myocardium, MAR, and salvageable myocardium. Firstly, as demonstrated in
Chapter 2, MP and ECDV thresholds, determined at the acute phase post insult, indicate
that MP lower than 0.44 ml/min/g represents infarcted myocardium, and ECDV values
greater than 0.36 ml/g represent MAR area. I concluded that the combination of these two
quantitative metrics was useful in determining the area of salvageable myocardium.
Section 3.3.4 will further discuss the importance of estimating both salvageable
myocardium and MAR for careful triage of patients for revascularization treatment.

3.2

Study Limitations

There are several limitations to the study presented in Chapter 2. First, this study was
limited to seven subjects, which may not suffice given that only two of these subjects
were non-MVO. The number of animals with non-MVO were underrepresented in this
study, and more animals are required to represent the patient population in clinical
settings. Secondly, the porcine animal model was not the ideal model of AMI. The
animal AMI model consisted of ischemia followed by reperfusion. This can mimic the
process of MI in UA and NSTEMI patients, but does not represent STEMI patients with
complete occlusions that do not reperfuse.
Although the validation of the functional CT technique was completed on acute and subacute phases after MI, evaluation of ECDV and MP to assess salvageable myocardium
was performed during acute phase after MI. Evaluation of ECDV and MP to estimate
salvageable myocardium in sub-acute and chronic MI in a greater population of animals
will be valuable.
Another technical limitation of this study was the variation in slice thickness between the
MR and CT images. The T2-w and gadolinium T1-map used for this study were 8 mm
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thick and the CT images were reconstructed at 5 mm slice thickness. Although the center
slices were used for analysis, slight differences in location of the heart can be detected.
The above limitation leads us to our second major limitation of this thesis work, which is
the absence of co-registration between different imaging methods. For example, slight
variation in slice location was seen between MR and CT, as well as between DCE-CT
and CI-CT. The later variation is due to the change in the subject’s heart rate between the
two acquired scans. This could have been minimized by co-registration of the images, but
due to the lack of rigidity in cardiac images and cardiac residual motion, attempts to do
so was unsuccessful.

3.3
3.3.1

Future Work
Monochromatic energy level to improve ECDV estimation

An advantage of dual energy CT used to image the subjects of this study is its ability to
use two different x-ray energies from a single energy source, to retrospectively
reconstruct a virtual monochromatic image. As implemented on the GE scanner, virtual
monochromatic images can be reconstructed at different energy levels. To reduce beamhardening artefacts, our previous studies (including the work in my thesis) used virtual
monochromatic images reconstructed at 70 keV. However, because the k-edge of iodine
is at 33 keV, we hypothesise that reconstructing virtual monochromatic images at an
energy closer to the k edge would result in higher contrast to noise ratio (CNR) of iodine
enhancement in the injured myocardium relative to the normal tissue, ECDV at two
different monochromatic energy levels were investigated.
In a preliminary evaluation, I reconstructed virtual monochromatic images at 50 keV for
six subjects (acute phase post insult), in addition to the 70 keV maps of Chapter 2, and
generated ECDV maps at 50 and 70 keV. Representative ECDV maps generated at 50
and 70 keV are shown in Figure 3-1. No significant difference was observed in normal
and injured myocardium between ECDV measurements estimated using retrospectively
reconstructed 50 keV and 70 keV monochromatic DCE-CT (Figure 3-2).
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Figure 3-1 ECDV functional maps generated at 70 keV and 50 keV of a single subject.
Graphs on the right illustrate the normalized time enhancement curves of the injured
apical septal wall (green) and normal mid-lateral myocardium (purple).

Figure 3-2 ECDV measurements (n=6) compared between images produced using 70
keV and 50 keV partial scan data. Error bars represent the standard error of the mean.
(ns denotes no significance (p > 0.05)).
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While our preliminary results yielded no statistical significance, further investigation
must be performed to understand why CNR did not improve in ECDV functional maps
generated from a monochromatic image closer to the k-edge of iodine.

3.3.2

Validation of four-minute scan duration in estimating ECDV

The functional CT technique for estimating ECDV is performed in approximately four
minutes. It consists of three phases: 1st phase: 22 axial scans at every 1-2 s, 2nd phase: 6
axial scans at every 14 s, 3rd phase: 4 axial scans at every 30 s. However, other labs have
emphasized that prolonged scan times - of up to ten minutes – are required to allow for
the measurement of the greatest amount of contrast retention in the injured myocardium
(12,13). To validate that our short, four-minute, dynamic imaging session is sufficient for
accurate estimation of ECDV, future work should compare ECDV measured from scans
that include a fourth phase that lasts up to 10 min. To provide preliminary validation, I
analysed data from two subjects, with acute AMI, which were scanned for up to ten
minutes; the additional 4th phase consisted of 6 axial scans acquired at 60 s intervals.
ECDV functional maps were generated using all four phases and compare to the ECDV
functional maps processed using only the three-phase data. The ECDV measurements
were compared in infarcted and normal myocardium. Figure 3-3 suggests that the
additional scans acquired up to 10 minutes do not change the measured ECDV. However,
further study is required to provide statistical significance and to evaluate equivalence in
cases with minimal perfusion, such as high degree of MVO.
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Figure 3-3 ECDV map of a two subjects (top and bottom row) at two different scan
durations. ECDV map corresponding to the short scan duration utilizing three phases
is shown on the left column and ECDV map corresponding to the long scan duration
utilizing four phases is shown on the right column. Infarcted myocardium is denoted
in orange and the normal (remote) myocardium is outlined in red.

3.3.3

Potential application of ECDV in sub-acute and chronic MI

For the majority of my thesis work, only data from the acute phase (day 3) post insult
were analyzed. The ECDV and MP thresholds were determined for subjects during the
acute phase after MI. Previous literature suggests that hemodynamics within the injured
tissue change as the heart begins its remodeling process (14,15). A major change that
takes place is the resolution of edema and the development of scar tissue. It would be
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interesting to test the potentials of ECDV and MP at later phases of MI to monitor the
change in area of salvageable myocardium for patients who do not receive treatment
within the ideal revascularization treatment window.
With DCE-CT, the change in contrast enhancement of the region of interest can be
monitored over time, and the distribution of contrast within the myocardium can be
assessed by adopting the JWL model of tracer kinetics. In the case of AMI, this technique
takes advantage of the edema and inflammation response after reperfusion. ECDV
quantification is a technique that may prove useful in other disease assessments as well,
one of which would be scar tissue identification in chronic MI patients.

Figure 3-4 Pathophysiology within infarcted myocardium at chronic MI. This figure
depicts the development of extracellular matrix composed of high concentration of
collagen fiber.
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During the chronic end stages of MI, the necrotic myocardium is replaced by collagenous
scar tissue—a healing process for the damaged heart (Figure 3-4) (15). The phases leading
to heart remodeling were divided into three stages by Richardson and colleagues:
inflammation/necrosis, fibrosis, and long-term heart remodeling. Our ECDV technique can
take advantage of the space of the extravascular compartment of excessively developed
extracellular matrix of scarred myocardium.
Following necrosis, the fibrotic stage can last from one to several weeks depending on the
degree of injury. During this phase, myofibroblast increase in abundance accompanied by
upregulation of matrix proteins and contractile abilities, specifically in areas of infarcted
myocardium. With careful regulations and balance of the above, collagen content
effectively increases. A compact extracellular matrix is structured by the cross-link of
many collagen fibers. The volume of space in which contrast agents can accumulate is
dependent on the density of the collagen fibers of the extracellular matrix. This assumption
has been tested using cardiac MR to image scar development at chronic stages of MI.

Figure 3-5 ECDV (left) and gadolinium enhanced MR (right) of a subject at acute MI
and chronic MI.
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Gadolinium enhanced MR for assessment of chronic MI has become an accepted standard
in detecting myocardial scar (16-18). Characterization of scar in terms of size and location
has proven useful in determining the clinical outcome of patients who have undergone
myocardium damage. Preliminary results of a single subject at the acute and chronic phases
of MI have demonstrated the potential of ECDV in characterizing chronic MI (Figure 35). Figure 3-5 shows enhancement in the injured myocardium region of a subject’s heart
imaged in short axis view, corresponding to the hypoenhanced area of a gadolinium
enhanced T1-map in acute and chronic MI. The retention of contrast that is shown through
the ECDV and gadolinium T1 map in acute phase MI is a result of edema; however, the
retention of contrast in injured myocardium at chronic phase MI results from the
development of fibrotic tissue. Further investigation with greater sample size is required to
test the use of ECDV in scar detection during chronic phase MI.

Figure 3-6 CMR Gd enhanced T1 map (left). ECDV and perfusion functional map
(top left and right, respectively). Iodine map at delayed phase and at peak contrast
enhancement (bottom left and right, respectively).
Another technique used in the clinic for scar detection is iodine mapping using dual energy
CT (19). Clinically, iodine mapping has been proposed to assess perfusion after a bolus
injection of contrast the hypoenhanced region was delineated on the CMR post gadolinium
T1 map representing the region affected by edema. The same region of interest was placed
on two iodine maps of the same subject: (1) at peak enhancement of contrast and (2) at
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delayed phase of injection (Figure 3-6). The preliminary data suggest that myocardial
absolute perfusion measurements and ECDV values obtained from the functional CT
technique may be more sensitive and provide quantitative information that may be more
valuable compared to the iodine map.

3.3.4

Clinical Translation: triaging patients for revascularization
treatment

The clinical motivation of my thesis work is to develop an imaging technique to triage
AMI patients for revascularization treatment. Upon patient admission to the hospital, they
are subjected to ECG-tracing and blood work as discussed in section 1.1.2. When the
patient is diagnosed with STEMI, clinicians can quickly conclude that the patient requires
urgent revascularization treatment. In situations where the patient remains asymptomatic
with inconclusive ECG and blood work, clinicians can rely on the functional CT
technique to estimate ECDV and MP. Quantitative ECDV and MP measurements can
then be used to delineate MAR and myocardial salvage. Although the functional CT
technique has the potential to be useful in the clinic, guidelines are required to properly
triage patients for intervention.
A useful measure for such guidelines is the calculation of the percentage of area that is
salvageable myocardium relative to the area of MAR. Once sufficient pre-clinical
evidence is acquired, a clinical study should be performed to determine a percentage
threshold of percent area of salvage myocardium to area of MAR to identify which
patients would most benefit from revascularization treatment.
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Appendices
Appendix A: Quality of ECDV functional maps using full scan and partial scan
retrospective reconstruction
The previously published paper adopted the use of full-scan reconstruction (1). However,
retrospective evaluation of the time enhancement curves indicated large variability in
measured average enhancement at the later time points (phases 2 and 3 of the
acquisition); see Figure A-1. This observation was consistent with observations made
during the acquisition where, near the end of the four-minute dynamic scan, subjects
were “fighting” against the manual breath-hold via ventilator. To reduce the effect of
motion during acquisition, the same set of raw DCE-CT projection data were
retrospectively reconstructed to produce partial-scan images for each of the seven
subjects at the acute phase. As describe in Chapter 2, images were averaged to produce 5mm thick slices and the dynamic scan images were registered to each other to minimize
motion artifact during the single dynamic imaging session (as per the full scan
reconstructed images). ECDV and MP functional maps were generated (Figure A-1)
using the extended JWL tracer kinetics model and the values within the myocardial
regions defined in Chapter 2 were calculated. Analysis was performed only on the ECDV
data.
Qualitatively, Figure A-1 shows greater difference between injured and normal
myocardium is seen in the ECDV maps derived from the partial scan reconstruction than
the full scan reconstruction. Quantitative comparison of the ECDV values in the apical
septal (injured) and mid-lateral (normal) walls of the myocardium obtained from the full
and partial scan are shown in Figure A-2. The figure shows greater difference in ECDV
between infarcted and normal myocardium when partial scan reconstruction is used (p<
0.0001) vs. full-scan reconstruction (p<0.05). Therefore, partial scan reconstruction was
utilized for the all data presented in this thesis.
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Figure A-1 ECDV and MP maps of a subject using full scan and partial scan
reconstruction. Graphs on the right illustrate the normalized time enhancement curves
of the injured apical septal wall (green) and normal mid-lateral myocardium (purple).
ECDV scale 0 to 1.2 ml/g and MP scale from 0 to 5.0 ml/min/g.

Figure A-2 ECDV (ml/g) of infarct and normal myocardium for each subject
compared using full scan and partial scan reconstruction. (* denote p < 0.05, ****
denote p < 0.0001).
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